Uptake and outcomes of intensity-modulated radiation therapy for uterine cancer

Gynecologic Oncology

Volumn 130, Issue 1, 2013, Pages 43-48

  Wright, Jason D ^a,c   Deutsch, Israel ^a,c   Wilde, Elizabeth T ^b   Ananth, Cande V ^a   Neugut, Alfred I ^a,b,c   Lewin, Sharyn N ^a,c   Siddiq, Zainab ^a   Herzog, Thomas J ^a,c   Hershman, Dawn L ^a,b,c  

^a College of Physicians and Surgeons ^*  (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

^c NewYork Presbyterian Hospital   (United States)

Author keywords

Endometrial cancer; IMRT; Intensity modulated radiation therapy; Pelvic radiation; Radiation; Uterine cancer

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CONTROLLED STUDY; DRUG UPTAKE; FEMALE; GASTROINTESTINAL TOXICITY; HEALTH CARE COST; HIP FRACTURE; HUMAN; HYSTERECTOMY; INTENSITY MODULATED RADIATION THERAPY; INTESTINE OBSTRUCTION; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIATION INJURY; UNITED STATES; UROGENITAL TRACT DISEASE; UTERUS CANCER;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INTESTINAL OBSTRUCTION; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; RADIATION INJURIES; RADIOTHERAPY, INTENSITY-MODULATED; SEER PROGRAM; TREATMENT OUTCOME; UNITED STATES; UTERINE NEOPLASMS;

EID: 84879115885     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.03.006     Document Type: Article

References (37)

1. H.M. Keys, J.A. Roberts, V.L. Brunetto, R.J. Zaino, N.M. Spirtos, and J.D. Bloss A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study Gynecol Oncol 92 3 2004 744 751
2. C.L. Creutzberg, W.L. van Putten, P.C. Koper, M.L. Lybeert, J.J. Jobsen, and C.C. Warlam-Rodenhuis Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC study group. Post operative radiation therapy in endometrial carcinoma Lancet 355 9213 2000 1404 1411
3. P. Blake, Am. Swart, J. Orton, H. Kitchener, T. Whelan, and H. Lukka Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis Lancet 373 9658 2009 137 146
4. H.D. Homesley, V. Filiaci, S.K. Gibbons, H.J. Long, D. Cella, and N.M. Spirtos A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study Gynecol Oncol 112 3 2009 543 552
5. A. Alvarez Secord, L.J. Havrilesky, V. Bae-Jump, J. Chin, B. Calingaert, and A. Bland The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer Gynecol Oncol 107 2 2007 285 291
6. W. Small Jr., L.K. Mell, P. Anderson, C. Creutzberg, J. Delos Santos, and D. Gaffney Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer Int J Radiat Oncol Biol Phys 71 2 2008 428 434
7. C.L. Creutzberg, W.L. van Putten, P.C. Koper, M.L. Lybeert, J.J. Jobsen, and C.C. Warlam-Rodenhuis The morbidity of treatment for patients with Stage I endometrial cancer: results from a randomized trial Int J Radiat Oncol Biol Phys 51 5 2001 1246 1255
8. A. Jhingran, K. Winter, L. Portelance, B. Miller, M. Salehpour, and R. Gaur A phase II study of intensity modulated radiation therapy to the pelvis for postoperative patients with endometrial carcinoma: radiation therapy oncology group trial 0418 Int J Radiat Oncol Biol Phys 84 1 2012 e23 e28
9. A.J. Mundt, L.K. Mell, and J.C. Roeske Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy Int J Radiat Oncol Biol Phys 56 5 2003 1354 1360
10. D.J. Sher, B.A. Neville, A.B. Chen, and D. Schrag Predictors of IMRT and conformal radiotherapy use in head and neck squamous cell carcinoma: a SEER-Medicare analysis Int J Radiat Oncol Biol Phys 81 4 2011 e197 e206
11. J.C. Roeske, D. Bonta, L.K. Mell, A.E. Lujan, and A.J. Mundt A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy Radiother Oncol 69 2 2003 201 207
12. C.J. Brixey, J.C. Roeske, A.E. Lujan, S.D. Yamada, J. Rotmensch, and A.J. Mundt Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies Int J Radiat Oncol Biol Phys 54 5 2002 1388 1396
13. A.J. Mundt, A.E. Lujan, J. Rotmensch, S.E. Waggoner, S.D. Yamada, and G. Fleming Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies Int J Radiat Oncol Biol Phys 52 5 2002 1330 1337
14. N.C. Sheets, G.H. Goldin, A.M. Meyer, Y. Wu, Y. Chang, and T. Sturmer Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer JAMA 307 15 2012 1611 1620
15. B.D. Smith, J.W. Pan, Y.C. Shih, G.L. Smith, J.R. Harris, and R. Punglia Adoption of intensity-modulated radiation therapy for breast cancer in the United States J Natl Cancer Inst 103 10 2011 798 809
16. J.P. Pignol, I. Olivotto, E. Rakovitch, S. Gardner, K. Sixel, and W. Beckham A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis J Clin Oncol 26 13 2008 2085 2092
17. M.K. Kam, S.F. Leung, B. Zee, R.M. Chau, J.J. Suen, and F. Mo Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients J Clin Oncol 25 31 2007 4873 4879
18. E.H. Pow, D.L. Kwong, A.S. McMillan, M.C. Wong, J.S. Sham, and L.H. Leung Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial Int J Radiat Oncol Biol Phys 66 4 2006 981 991
19. A. Ahamad, W. D'Souza, M. Salehpour, R. Iyer, S.L. Tucker, and A. Jhingran Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size Int J Radiat Oncol Biol Phys 62 4 2005 1117 1124
20. L. Portelance, K.S. Chao, P.W. Grigsby, H. Benneth, and D. Low Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation Int J Radiat Oncol Biol Phys 51 1 2001 261 266
21. E. Wong, D.P. D'Souza, J.Z. Chen, M. Lock, G. Rodrigues, and T. Coad Intensity-modulated arc therapy for treatment of high-risk endometrial malignancies Int J Radiat Oncol Biol Phys 61 3 2005 830 841
22. A.E. Lujan, A.J. Mundt, S.D. Yamada, J. Rotmensch, and J.C. Roeske Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy Int J Radiat Oncol Biol Phys 57 2 2003 516 521
23. Y. Liang, M. Bydder, C.M. Yashar, B.S. Rose, M. Cornell, and C.K. Hoh Prospective study of functional bone marrow-sparing intensity modulated radiation theraphy with concurrent chemotheraphy for pelvic malignancies Int J Radiat Oncol Biol Phys 85 2 2012 406 414
24. A.L. Potosky, G.F. Riley, J.D. Lubitz, R.M. Mentnech, and L.G. Kessler Potential for cancer related health services research using a linked Medicare-tumor registry database Med Care 31 8 1993 732 748
25. X. Du, J.L. Freeman, J.L. Warren, A.B. Nattinger, D. Zhang, and J.S. Goodwin Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer Med Care 38 7 2000 719 727
26. J.L. Warren, C.N. Klabunde, D. Schrag, P.B. Bach, and G.F. Riley Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population Med Care 40 8 Suppl. 2002 IV-3 IV-18
27. D.L. Hershman, D.L. Buono, J. Malin, R. Mcbride, W.Y. Tsai, and Al. Neugut Patterns of use and risks associated with erythropoiesis-stimulating agents among Medicare patients with cancer J Natl Cancer Inst 101 23 2009 1633 1641
28. X.L. Du, S. Fang, S.W. Vernon, H. El-Serag, Y.T. Shih, and J. Davila Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer Cancer 110 3 2007 660 669
29. M.E. Charlson, F.L. Sax, C.R. MacKenzie, S.D. Fields, R.L. Braham, and R.G. Douglas Jr. Assessing illness severity: does clinical judgment work? J Chronic Dis 39 6 1986 439 452
30. C.N. Klabunde, A.L. Potosky, J.M. Legler, and J.L. Warren Development of a comorbidity index using physician claims data J Clin Epidemiol 53 12 2000 1258 1267
31. J.D. Wright, A.I. Neugut, E.T. Wilde, D.L. Buono, W.Y. Tsai, and D.L. Hershman Use and benefits of laparoscopic hysterectomy for stage I endometrial cancer among Medicare beneficiaries J Oncol Pract 8 5 2012 e89 e99
32. J.D. Wright, J. Fiorelli, P.B. Schiff, W.M. Burke, A.L. Kansler, and C.J. Cohen Racial disparities for uterine corpus tumors: changes in clinical characteristics and treatment over time Cancer 115 6 2009 1276 1285
33. M.L. Brown, G.F. Riley, N. Schussler, and R. Etziono Estimating health care costs related to cancer treatment from SEER-Medicare data Med Care 40 8 Suppl. 2002 IV-104 IV-117
34. J.L. Warren, K.R. Yabroff, A. Meekins, M. Topor, E.B. Lamont, and M.L. Brown Evaluation of trends in the cost of initial cancer treatment J Natl Cancer Inst 100 12 2008 888 897
35. P.D. Allison Logistic regression using SAS: theory and application 2012 SAS Institute Inc. Cary, North Carolina
36. R. Koenker Quantile regression 2005 Cambridge University Press New York
37. B.A. Guadagnolo, C.C. Liu, J.N. Cormier, and X.L. Du Evaluation of trends in the use of intensity-modulated radiotherapy for head and neck cancer from 2000 through 2005: socioeconomic disparity and geographic variation in a large population-based cohort Cancer 116 14 2010 3505 3512